Literature DB >> 30238201

Biliary Decompression in Perihilar Cholangiocarcinoma Improves Survival: A Single-Center Retrospective Analysis.

Lisa S Cassani1,2,3, Jay Chouhan4, Christopher Chan4, Gandhi Lanke4, Hsiang-Chun Chen5, Xuemei Wang5, Brian Weston4, William A Ross4, Gottumukkala S Raju4, Jeffrey H Lee4.   

Abstract

BACKGROUND AND AIMS: The complex biliary strictures of perihilar cholangiocarcinoma present significant challenges for providing adequate and long-lasting biliary drainage. The best approach to relieve obstruction remains controversial. The purpose of this study was to assess stenting outcomes in perihilar cholangiocarcinoma.
METHODS: This study was approved by the center's institutional review board. Subjects with a diagnosis of perihilar cholangiocarcinoma who underwent endoscopic retrograde cholangiopancreatography (ERCP) were identified from endoscopic and pathologic databases from 1997 to 2014. Patient characteristics, endoscopic data, and follow-up evaluation data were retrospectively collected via review of available medical records.
RESULTS: A total of 199 patients with perihilar cholangiocarcinoma who underwent a total of 504 ERCPs were included in the study. Nine of 504 (1.8%) procedures were technical failures. Among the 495 technically successful procedures, 347 (70.1%) procedures were clinical successes. Clinical success was significantly associated with longer overall survival (HR 0.57; p = 0.002). A higher proportion of patients with bilateral drainage had clinical success, compared with those with unilateral drainage. Cholangitis was not more common in the bilateral group compared to the unilateral group except in the group where a segment was not drained (1.9% vs 1.6% vs 7.1%, respectively). Patients with metal stents were 3.8 times more likely to have clinical success than those with plastic stents.
CONCLUSIONS: In conclusion, adequate biliary drainage improves overall survival. Bilateral stenting if anatomy permits with self-expanding metal stents rather than plastic stents appears to provide the optimal chance of clinical success.

Entities:  

Keywords:  Biliary drainage; Cholangiocarcinoma; Cholangitis; Endoscopic retrograde cholangiopancreatography; Klatskin tumor; Self-expanding metal stent

Mesh:

Year:  2018        PMID: 30238201     DOI: 10.1007/s10620-018-5277-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial.

Authors:  Apichat Sangchan; Worrarat Kongkasame; Ake Pugkhem; Kriangsak Jenwitheesuk; Pisaln Mairiang
Journal:  Gastrointest Endosc       Date:  2012-05-15       Impact factor: 9.427

2.  Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study.

Authors:  G D De Palma; G Galloro; S Siciliano; P Iovino; C Catanzano
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

3.  Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.

Authors:  Masato Nagino; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yu Takahashi; Yuji Nimura
Journal:  Ann Surg       Date:  2013-07       Impact factor: 12.969

4.  Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage.

Authors:  W H Chang; P Kortan; G B Haber
Journal:  Gastrointest Endosc       Date:  1998-05       Impact factor: 9.427

5.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

6.  Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.

Authors:  Sarwa Darwish Murad; W Ray Kim; Denise M Harnois; David D Douglas; James Burton; Laura M Kulik; Jean F Botha; Joshua D Mezrich; William C Chapman; Jason J Schwartz; Johnny C Hong; Jean C Emond; Hoonbae Jeon; Charles B Rosen; Gregory J Gores; Julie K Heimbach
Journal:  Gastroenterology       Date:  2012-04-12       Impact factor: 22.682

7.  Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment.

Authors:  Ariane Vienne; Ehlam Hobeika; Hervé Gouya; Nathanael Lapidus; Jacques Fritsch; André Daniel Choury; Ariane Chryssostalis; Marianne Gaudric; Gilles Pelletier; Catherine Buffet; Stanislas Chaussade; Frédéric Prat
Journal:  Gastrointest Endosc       Date:  2010-10       Impact factor: 9.427

8.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.

Authors:  Woo Hyun Paik; Young Soo Park; Jin-Hyeok Hwang; Sang Hyub Lee; Chang Jin Yoon; Sung-Gwon Kang; Jae Kyung Lee; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon
Journal:  Gastrointest Endosc       Date:  2008-07-26       Impact factor: 9.427

10.  Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients.

Authors:  Manuel José Antunes Liberato; Jorge Manuel Tavares Canena
Journal:  BMC Gastroenterol       Date:  2012-08-09       Impact factor: 3.067

View more
  5 in total

1.  Endoscopic Management of Cholangiocarcinoma: Putting in Your Two Stents' Worth.

Authors:  Daniel S Strand
Journal:  Dig Dis Sci       Date:  2019-02       Impact factor: 3.199

2.  A preliminary single-center investigation of percutaneous biliary stenting in malignant hilar biliary obstruction: what impacts the clinical success and the long-term outcomes?

Authors:  Xiaonan Mao; Feng Wen; Hongyuan Liang; Wei Sun; Zaiming Lu
Journal:  Support Care Cancer       Date:  2021-05-14       Impact factor: 3.603

3.  Endoscopic Retrograde Cholangiopancreatography (ERCP) in Patients With Liver Cirrhosis: Analysis of Trends and Outcomes From the National Inpatient Sample Database.

Authors:  Shantanu Solanki; Asim Kichloo; Dushyant S Dahiya; Dhanshree Solanki; Jagmeet Singh; Farah Wani; Michael Albosta; Subash Ghimire; Khwaja F Haq; Hafiz M A Khan; Syed-Mohammed Jafri; Mohammad Arsalan Siddiqui; Tobias Zuchelli
Journal:  J Clin Gastroenterol       Date:  2021-06-09       Impact factor: 3.174

4.  Unilateral versus bilateral hilar stents for the treatment of cholangiocarcinoma: a multicenter international study.

Authors:  Judith Staub; Ali Siddiqui; Megan Murphy; Robert Lam; Meet Parikh; Douglas Pleskow; Georgios Papachristou; Reem Sharaiha; Usama Iqbal; David Loren; Thomas Kowalski; Arish Noor; Tayebah Mumtaz; Ichiro Yasuda; Samuel Thomas; Abdul Hsaeeb; Jennifer Herrick; Tom Greene; Douglas G Adler
Journal:  Ann Gastroenterol       Date:  2020-02-12

5.  A single-center retrospective study comparing safety and efficacy of endoscopic biliary stenting only vs. EBS plus nasobiliary drain for obstructive jaundice.

Authors:  Huan Liu; Chuanke Shi; Zhideng Yan; Ming Luo
Journal:  Front Med (Lausanne)       Date:  2022-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.